Intermountain Primary Children's Hospital and University of Utah Health are taking a big swing at the medical mystery game with Primary Children's Gene Kids, a new program that expands access to whole genome sequencing for infants and children across the Intermountain West. The three-year, $9 million effort is built to deliver faster genetic diagnoses and a lifelong "personal genome" for each enrolled child. Hospital leaders say the initiative is focused on young patients seen in cardiology, neurology, neuromuscular clinics, and in the NICU, and is structured to reach families in rural and underserved communities across the region.
New Funding And What It Covers
Primary Children's Gene Kids is backed by $9 million in philanthropic support, including a $4.5 million grant from The Warren Alpert Foundation that was matched by donations to Intermountain Health's Primary Promise campaign, according to Intermountain Health. Dustin Lipson, president of Intermountain Primary Children's Hospital, said the funding will support staffing, central research protocols, data storage, and expanded genomic testing across the region. The same materials describe the program's goal of returning genome results rapidly to families and creating a lifelong record that can be re-analyzed as science advances.
Faster Answers Through AI And Partnerships
The initiative pairs the University of Utah-developed genomic databases and AI tools with clinical sequencing to scale diagnoses. University of Utah Health reports that the pipeline can generate genome analysis in a week or less and uses AI to sift through clinical notes to flag likely genetic cases. To speed turnaround even further, Intermountain has teamed up with Broad Clinical Labs and Fabric Genomics to provide a "sample-to-report" service that can identify genetic disorders within days rather than weeks, according to a release from Business Wire. Program leaders say combining local research expertise with outside sequencing partners is key to reaching children across roughly 400,000 square miles of the Intermountain West.
Real Families, Real Impact
Clinicians point to families like that of 7-year-old Scarlet Hill, whose second round of genomic testing finally produced a diagnosis that connected her to others with the same condition and helped refine her care, as reported by KSL. Parents and doctors say that re-analysis of stored genomes can yield answers years after an initial negative test, and those results can change care plans or open the door to clinical trials and support networks. Scarlet's story is held up as an example of the program's potential to shorten long diagnostic odysseys and give families clearer roadmaps for treatment.
Who Can Enroll And How To Get Started
Potential participants are identified by their providers, and the program prioritizes infants and children with suspected genetic disorders who are seen in cardiology, neurology, genetics, and the NICU, according to materials from Intermountain Health. The program's FAQ states that sequencing will be covered in cases where it cannot be obtained through usual clinical pathways, and program leaders say they plan to use telemedicine and community outreach to extend testing into rural and underserved clinics. Hospital teams are currently working to build the operational and data infrastructure needed to deliver testing at scale across the region.
